Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/1992
02/20/1992WO1991004059A3 Method and useful apparatus for preparing pharmaceutical compositions
02/20/1992DE4025725A1 Monoklonale antikoerper, die mit human- und ratteninsulin bindefaehig sind Monoclonal antibodies that are human and rat insulin with bindefaehig
02/20/1992CA2088246A1 Gene encoding equine herpesvirus type i glycoprotein d, its gene product, antibodies and their uses
02/20/1992CA2088164A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers
02/19/1992EP0471660A2 Protein C for treating pain
02/19/1992EP0471356A1 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof
02/19/1992EP0471345A1 Determination of biogenous amines
02/19/1992EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein
02/19/1992EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these
02/19/1992EP0428518A4 Monoclonal antibodies specific for the harvey, kirsten and n ras proteins and their use as diagnostic reagents
02/18/1992WO1992003159A1 New peptides and their use
02/18/1992US5089605 Immobilized immunoglobulin-binding proteins
02/18/1992US5089603 Antigenic epitopes present on membrane-bound but not secreted iga
02/18/1992US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators
02/18/1992US5089262 Diagnosis, therapy
02/18/1992CA2089660A1 New peptides and their use
02/18/1992CA1295960C Monoclonal antibody
02/18/1992CA1295937C Method for the evaluation of oral microbes
02/16/1992CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein
02/15/1992CA2048895A1 Antigenic peptide for detecting anti-hepatitis c virus antibodies and use thereof
02/14/1992WO1992003466A1 Lymphokine 154
02/14/1992CA2089258A1 Lymphokine 154
02/14/1992CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same
02/13/1992DE4125188A1 Granulocyten hemmendes polypeptid Granulocyte inhibitory polypeptide
02/13/1992DE4025499A1 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen Use of antibodies BR55-2, derivatives thereof, and fragments conjugate on HIV infections
02/12/1992EP0470565A1 Peptides with antigenic determinant characteristic for alpha 1-microglobulin
02/11/1992WO1992002815A2 Quantitative analysis and monitoring of protein structure by subtractive chromatography
02/11/1992US5087952 Lipid-protein compositions and articles and methods for their preparation
02/11/1992US5087696 Conjugate compound
02/11/1992US5087695 Washing precipitate with ethylendiaminetetraacetic acid to remove lipids and suspending immunoglobulins in a fluid containing lysine or arginine hydrochloride and sodium bicarbonate
02/11/1992US5087693 Bovine monoclonal antibodies to bovine herpesvirus I from sequential fusion heterohybrodimas
02/11/1992US5087573 Monoclonal antibody against bone alkaline phosphatase
02/11/1992US5087560 Monoclonal antibody for use in drug resistant cancers and production thereof
02/11/1992US5087557 Human monoclonal antibody to lymphadenopathy-associated virus
02/11/1992US5087369 Absorption using rotation affinity gel carrier
02/11/1992CA2088360A1 Quantitative analysis and monitoring of protein structure by substractive chromatography
02/11/1992CA2048899A1 Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment
02/11/1992CA1295562C DNA SEQUENCES CODING FOR THE DR.beta.-CHAIN LOCUS OF THE HUMAN LYMPHOCYTE ANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING PROCESSES AND PRODUCTS RELATED THERETO
02/10/1992WO1992002629A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors
02/10/1992CA2088905A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors
02/09/1992WO1992002621A2 Allergens of alder pollen and applications thereof
02/09/1992CA2067144A1 Allergens of alder pollen and applications thereof
02/08/1992CA2047902A1 Chromatography cartridge
02/07/1992CA2048305A1 Peptides with a characteristic antigenic determinant for alphal-microglobulin
02/06/1992WO1992001816A1 Human herpesvirus-7
02/06/1992WO1992001807A1 Means for diagnosis of ta and anti-ta antibodies and biological applications
02/06/1992WO1992001791A1 Method of preparation of vaccines, and the use of the vaccines thus prepared
02/06/1992WO1992001782A2 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells
02/06/1992WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140
02/06/1992WO1992001717A1 Bacterial stress proteins
02/06/1992WO1992001713A1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses
02/06/1992WO1992001473A1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
02/06/1992WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
02/06/1992WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation
02/06/1992WO1992001460A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
02/06/1992CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
02/06/1992CA2087160A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
02/06/1992CA2087100A1 Immunotherapeutic method of preventing or treating viral respiratory tract disease
02/05/1992EP0469897A2 Engineered antibodies
02/05/1992EP0469359A2 Method and product for the treatment of gastric disease
02/05/1992EP0191772B1 Acid-cleavable compound
02/03/1992WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms
02/03/1992WO1992002253A1 INTERLEUKIN-4 AND INTERLEUKIN-1β SYNERGISTICALLY INDUCE VCAM-1
02/02/1992CA2088499A1 Dynemicin analogs: syntheses, methods of preparation and use
01/1992
01/30/1992DE4107765A1 Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt Pancreatic elastase-1-specific antibodies, a process for its production and to a test kit which such antibody contains
01/30/1992DE4023945A1 Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern A process for purification of cytokeratin 20 and its use for the production of antibodies
01/30/1992DE4023721A1 Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s)
01/29/1992WO1992002630A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
01/29/1992EP0468637A1 In vivo targeting with bifunctional antibodies
01/29/1992EP0468601A1 Methods and materials for HIV detection and therapy
01/29/1992EP0468527A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
01/29/1992EP0468504A1 A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical
01/29/1992EP0468441A1 Use of particular compounds for manufacture of pharmaceutical formulations for metabolic treatments
01/29/1992EP0468056A1 Anti-procollagenase monoclonal antibodies and a method for the assay of procollagenase utilizing thereof
01/29/1992EP0468049A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen
01/29/1992EP0467992A1 Process for purifying a protein
01/29/1992EP0467987A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system
01/29/1992EP0467965A1 Plasmodium circumsporozoite protein analogs lacking repeat sequences
01/29/1992EP0467932A1 Urokinase-type plasminogen activator receptor
01/28/1992WO1992002542A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity
01/28/1992US5084559 Protein a domain mutants
01/28/1992US5084396 Monoclonal antibodies absorbed onto a matrix and binding, mixing with a polyvalent antigen to form an immune complex, immunizing animals, fusion spleen cells to form hybridomas and culturing
01/28/1992US5084391 Monoclonal antibody to the interleukin-2-receptor and its use
01/28/1992US5084380 Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
01/28/1992CA2088162A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity
01/28/1992CA2047388A1 Aeromonas salmonicida
01/28/1992CA1294906C Monoclonal antibodies to cruciform dna structure
01/28/1992CA1294905C Anti-lafora body monoclonal antibody
01/28/1992CA1294904C Progesterone assay method for mammals
01/28/1992CA1294903C Monoclonal antibodies and test method for detection of gluten in foods
01/28/1992CA1294902C Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
01/28/1992CA1294901C Monoclonal antibody specific for human colon fibroblast-derived t-pa
01/27/1992WO1992001935A1 Cell necrosis detection through assays for spectrin and breakdown products thereof
01/27/1992CA2088050A1 Cell necrosis detection through assays for spectrum and breakdown products thereof
01/26/1992WO1992001787A1 Binding domains
01/26/1992CA2087095A1 Binding domains
01/25/1992WO1992001469A1 A composition providing improved clearance of bioactive substances from the bloodstream
01/25/1992CA2087971A1 Composition providing improved clearance of bioactive substances from the bloodstream
01/24/1992CA2047618A1 Use of particular compounds for manufacture of pharmaceutical formulations for metabolic treatments
01/23/1992WO1992001227A1 Immunodiagnostic reagent specific for legionella